Latest filing published 07 Feb 2024 for Alto Neuroscience, Inc..
No signal scores available.
Christopher Nixon Cox discloses dealings in Alto Neuroscience, Inc. to SEC (Form 4). Altogether 2 filings, all relating to 6 February 2024.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 7 February 2024: a transaction, in Alto Neuroscience, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations